🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This study is being conducted in patients with newly diagnosed breast cance...
Status
Completed
Location
Columbia University Irving Medical Center
Start Date
2012-10
Trial ID
NCT01847001
The purpose of this study is to establish a prospective, single-center plat...
Status
Recruiting
Location
Fudan University Shanghai Cancer Center Shanghai, China, 200032
Start Date
2022-11-01
Trial ID
NCT05582499
Treatments Being Tested
SMMART-ACT is a feasibility pilot study to determine if testing samples fro...
Status
Withdrawn
Location
Multiple Locations
Start Date
2023-01-30
Trial ID
NCT05238831
Treatments Being Tested
This phase II trial studies how well pertuzumab, trastuzumab, and paclitaxe...
Status
Completed
Location
City of Hope Medical Center
Start Date
2013-07-17
Trial ID
NCT01730833
Adult men and women with early-stage, IHC/FISH-defined HER2-positive breast...
Status
Recruiting
Location
University of Illinois
Start Date
2024-12-05
Trial ID
NCT06441890
Treatments Being Tested
This study aims to evaluate the efficacy and safety of pyrotinib in combina...
Status
Active Not Recruiting
Location
Ruijin Hospital, Shanghai Jiaotong University School of Medicine
Start Date
2020-05-30
Trial ID
NCT04398914
Treatments Being Tested
Patients with Stage II-III HER2-positive breast cancer will receive three c...
Status
Recruiting
Location
Shanghai Jiaotong University School of Medicine affiliated Ruijin Hospital
Start Date
2026-02-02
Trial ID
NCT07393425
The study consists of a screening period of 28 days, a treatment period. Lo...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2025-12-15
Trial ID
NCT07245797
This phase II, multicenter, open-label, randomized controlled trial (FACET ...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2026-10-01
Trial ID
NCT07716046
Treatments Being Tested
This prospective, response-guided phase II study investigates individualize...
Status
Recruiting
Location
2nd Affiliated Hospital, School of Medicine, Zhejiang University
Start Date
2025-12-25
Trial ID
NCT07340398
Treatments Being Tested